Drugs that affect noradrenaline release
|
DRUGS THAT AFFECT NORADRENALINE RELEASE
|
Guanethidine
- It is selectively inhibits release of noradrenaline from peripheral postganglionic adrenergic neurons, with no effect on adrenal medulla.
- Mechanism of action
-
-
It has bretylium like effect-blocks nerve impulse coupled release of stored noradrenaline
-
Tyramine like effect-displaces noradrenaline from storage vesicles
-
Reserpine like effect-causes gradual depletion of noradrenaline in storage vesicles
-
Blocks uptake1 carrier transport system for noradrenaline
-
When chronically administered guanethidine acts as a “substitute neurotransmitter”, as it is stored noradrenaline storage vesicles and is released by stimuli that normally release noradrenaline.
-
Has some local anesthetic like action
-
Guanethidine in large doses caused structural damage to adrenergic neurons.
- Pharmacological effects
-
Following oral administration, guanethidine produces fall in blood pressure and bradycardia, because of decreased release of noradrenaline. However, after IV administration, it produces characteristic triphasic response in blood pressure.
-
Initially it produces decrease in blood pressure (due to decreased peripheral resistance an cardiac output, resulting from initial noradrenaline blockade).
-
The fall is then followed by increase in blood pressure (due to release of noradrealine) and then finally there is fall in blood pressure ( due to depletion of noradrenaline).
- Clinical uses: Seldom used in veterinary practice.
Bretylium
-
Inhibits the release of noradrenaline, accumulates in nerve terminals and exerts a selective local anesthetic effect on sympathetic nerve terminals.
-
It does not block release of catecholamines from adrenal medulla and does not affect nerve terminals other than those that release nor adrenaline.
-
Bretylium also has effect on K+ channels in myocardium and exerts anti arrhythmic effect.
|
Last modified: Monday, 17 October 2011, 7:12 AM